Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.48%841.4K | -22.24%407.15K | 9.15%713.49K | -4.51%2.74M | -1.16%675.03K | -12.07%890.21K | -26.64%523.63K | 41.23%653.66K | 17.81%2.87M | 25.87%682.96K |
| Operating revenue | -5.48%841.4K | -22.24%407.15K | 9.15%713.49K | -4.51%2.74M | -1.16%675.03K | -12.07%890.21K | -26.64%523.63K | 41.23%653.66K | 17.81%2.87M | 25.87%682.96K |
| Cost of revenue | -13.73%435.2K | -37.38%169.42K | 27.13%341.18K | -8.43%1.4M | -9.80%360.1K | 0.35%504.45K | -30.76%270.53K | 11.80%268.38K | 25.80%1.53M | 79.48%399.22K |
| Gross profit | 5.30%406.21K | -6.07%237.73K | -3.37%372.3K | -0.02%1.34M | 10.99%314.93K | -24.32%385.76K | -21.67%253.1K | 72.95%385.28K | 9.83%1.34M | -11.37%283.75K |
| Operating expense | -14.65%464.43K | -14.89%530.67K | -19.21%461.27K | 19.03%2.25M | 2.26%506.23K | -17.08%544.17K | 111.57%623.5K | 29.70%570.94K | 4.68%1.89M | 21.83%495.05K |
| Selling and administrative expenses | -15.57%403.69K | -14.94%474.16K | -21.20%390.2K | 21.80%1.96M | -8.56%421.49K | -16.42%478.14K | 164.80%557.44K | 36.17%495.19K | 6.62%1.61M | 39.74%460.97K |
| -Selling and marketing expense | -25.08%198.57K | -33.66%195.74K | -27.57%196.08K | 17.96%1.03M | -24.54%206.02K | 5.81%265.05K | 51.60%295.06K | 72.92%270.73K | 16.91%874.73K | 65.04%273.03K |
| -General and administrative expense | -3.74%205.12K | 6.11%278.42K | -13.51%194.13K | 26.38%925.75K | 14.65%215.47K | -33.74%213.08K | 1,552.05%262.38K | 8.39%224.46K | -3.52%732.51K | 14.29%187.94K |
| Research and development costs | -13.88%24.21K | -28.16%20.25K | -7.04%35.32K | 13.51%129.32K | 31.50%40.06K | 2.71%28.11K | -5.02%28.19K | 43.84%37.99K | 21.48%113.93K | 0.48%30.47K |
| Depreciation amortization depletion | -3.67%36.53K | -4.27%36.25K | -5.33%35.75K | -4.11%158.23K | 1,136.16%44.68K | -33.18%37.92K | -30.53%37.87K | -24.68%37.76K | -17.78%165.02K | -92.17%3.61K |
| -Depreciation and amortization | -3.67%36.53K | -4.27%36.25K | -5.33%35.75K | -4.11%158.23K | 1,136.16%44.68K | -33.18%37.92K | -30.53%37.87K | -24.68%37.76K | -17.78%165.02K | -92.17%3.61K |
| Operating profit | 63.25%-58.22K | 20.91%-292.94K | 52.08%-88.96K | -65.69%-906.12K | 9.47%-191.29K | -8.11%-158.41K | -1,404.55%-370.4K | 14.62%-185.65K | 6.10%-546.87K | -145.14%-211.31K |
| Net non-operating interest income (expenses) | -9.79%-8.23K | -5.53%-8.44K | 0.89%-8.54K | 13.87%-32.61K | -138.05%-8.51K | 61.22%-7.5K | 60.18%-8K | 58.60%-8.62K | 54.73%-37.86K | 207.20%22.36K |
| Non-operating interest income | -21.27%8.24K | -19.79%8.82K | -18.48%9.38K | 2.52%42.9K | -76.27%9.93K | --10.47K | --11K | --11.51K | --41.85K | --41.85K |
| Non-operating interest expense | -8.31%16.47K | -9.13%17.26K | -10.95%17.92K | -5.27%75.51K | -5.44%18.44K | -7.07%17.96K | -5.42%18.99K | -3.29%20.12K | -4.70%79.71K | -6.52%19.5K |
| Other net income (expenses) | -159.77%-20.48K | 29.52%40.17K | 357.66%71.29K | 84.12%-13.83K | -7.55%-60.92K | 209.33%34.26K | 1,393.99%31.02K | -941.45%-27.67K | -313.30%-87.09K | -24.49%-56.64K |
| Gain on sale of security | -159.77%-20.48K | 29.52%40.17K | 357.66%71.29K | 85.68%-13.83K | 22.19%-51.44K | 209.33%34.26K | 1,393.99%31.02K | -941.45%-27.67K | -162.77%-96.56K | -197.93%-66.11K |
| Special income (charges) | --0 | --0 | ---- | --0 | -200.00%-9.47K | --0 | --0 | ---- | 108.38%9.47K | --9.47K |
| -Gain on sale of property,plant,equipment | --0 | --0 | ---- | --0 | ---9.47K | --0 | --0 | ---- | --9.47K | ---- |
| Income before tax | 33.97%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.24%-131.64K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 33.97%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.24%-131.64K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Net income continuous operations | 33.97%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.24%-131.64K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 33.97%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.24%-131.64K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 33.97%-86.93K | 24.81%-261.2K | 88.19%-26.22K | -41.79%-952.56K | -6.16%-260.72K | 33.24%-131.64K | -5,971.87%-347.38K | 5.54%-221.94K | -7.45%-671.81K | -60.99%-245.59K |
| Diluted earnings per share | -0.01 | 0.00%-0.01 | 0 | -100.00%-0.02 | -0.01 | 0 | -9,533.96%-0.01 | 0 | 10.37%-0.01 | 0 |
| Basic earnings per share | -0.01 | 0.00%-0.01 | 0 | -100.00%-0.02 | -0.01 | 0 | -9,533.96%-0.01 | 0 | 10.37%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.